Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,7.709318363636893e-40,116.60823754789271,10501.851443629172,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",2.4746911947274426e-37,0,0,67
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,1.0875955364147929e-20,27.143795620437956,1247.738736934216,"['NDUFB9', 'COX7B', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX4I1', 'COX17', 'NDUFB3', 'NDUFB2', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'UCP3', 'UQCRFS1', 'ATP5MF', 'ATP5ME', 'COX8A', 'ATP5PF', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA1', 'NDUFC1', 'COX6C', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'SLC25A5']",1.7455908359457424e-18,0,0,41
3,Nonalcoholic fatty liver disease WP4396,2.701383627513585e-16,15.173686594202898,543.9402079740871,"['NDUFB9', 'NDUFA13', 'COX7B', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'UQCRFS1', 'CYC1', 'COX8A', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA1', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'CYCS', 'BAX']",2.8904804814395356e-14,0,0,37
4,Mitochondrial complex I assembly model OXPHOS system WP4324,3.365391707576381e-11,inf,inf,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFA5', 'NDUFB11', 'NDUFB5', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFC1', 'TMEM186', 'NDUFS6', 'NDUFS5']",2.700726845330046e-09,0,0,17
5,Oxidative phosphorylation WP623,6.096318875221733e-09,15.125,286.0981582539155,"['NDUFB9', 'ATP5PF', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'ATP5PD', 'NDUFB10', 'NDUFA5', 'NDUFB5', 'NDUFA4', 'NDUFB2', 'NDUFC1', 'ATP5F1E', 'ATP5MC1', 'NDUFS6', 'NDUFS5', 'ATP5MF', 'ATP5ME']",3.9138367178923526e-07,0,0,19
6,Mitochondrial CIV Assembly WP4922,2.7083326694413256e-06,11.047826086956523,141.6240420903057,"['COX8A', 'COX7B', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX7C', 'COX6B1', 'SCO2', 'COX14']",0.0001448957978151109,0,0,14
7,Mitochondrial complex III assembly WP4921,1.2358491650769654e-05,inf,inf,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.0005667251171281513,0,0,8
8,Selenium Micronutrient Network WP15,0.035106490317845594,2.7691719257984317,9.274979313577566,"['SELENOM', 'PRDX5', 'GPX4', 'SELENOW', 'SELENOK', 'PTGS2', 'SEPHS2', 'SELENOH']",0.9930663776353466,0,0,8
9,Pyrimidine metabolism WP4022,0.035106490317845594,2.7691719257984317,9.274979313577566,"['NT5C', 'POLD4', 'NME2', 'POLR2I', 'DCTPP1', 'POLR2K', 'NME1', 'POLR2L']",0.9930663776353466,0,0,8
10,Nanoparticle triggered regulated necrosis WP2513,0.047656059236901346,9.30716723549488,28.32864835026317,"['TRADD', 'FADD', 'FTL']",0.9930663776353466,0,0,3
11,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.0597528196782748,inf,inf,"['COX8A', 'GSTP1']",0.9930663776353466,0,0,2
12,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.0597528196782748,inf,inf,"['HOMER1', 'HRAS']",0.9930663776353466,0,0,2
13,CAMKK2  Pathway WP4874,0.0597528196782748,inf,inf,"['FIS1', 'MAP1LC3A']",0.9930663776353466,0,0,2
14,Cellular Proteostasis WP4918,0.0597528196782748,inf,inf,"['VBP1', 'PFDN5']",0.9930663776353466,0,0,2
15,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.0597528196782748,inf,inf,"['LDHA', 'HLA-DRA']",0.9930663776353466,0,0,2
16,DNA IR-double strand breaks and cellular response via ATM WP3959,0.06540010934301467,4.139031339031339,11.288096020680701,"['DCLRE1C', 'KAT5', 'CHEK2', 'BAX']",0.9930663776353466,0,0,4
17,Nanomaterial induced apoptosis WP2507,0.06540010934301467,4.139031339031339,11.288096020680701,"['ENDOG', 'BAX', 'CYCS', 'FADD']",0.9930663776353466,0,0,4
18,Cytosolic DNA-sensing pathway WP4655,0.07156434533673768,3.106164383561644,8.191447182792604,"['MAVS', 'TRADD', 'FADD', 'POLR2K', 'POLR2L']",0.9930663776353466,0,0,5
19,ATM Signaling Network in Development and Disease  WP3878,0.09768596851843249,4.651023890784983,10.81826923674271,"['DCLRE1C', 'KAT5', 'CHEK2']",0.9930663776353466,0,0,3
20,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.09768596851843249,4.651023890784983,10.81826923674271,"['MAP1LC3A', 'IGFBP5', 'TNFSF9']",0.9930663776353466,0,0,3
21,p38 MAPK Signaling Pathway WP400,0.09768596851843249,4.651023890784983,10.81826923674271,"['TRADD', 'DDIT3', 'HRAS']",0.9930663776353466,0,0,3
22,Ciliary landscape WP4352,0.14586229247295132,1.7752643225965086,3.4175476860774325,"['EXOSC4', 'TTC30B', 'NDUFA5', 'COPS7A', 'MYL6B', 'RAB3IL1', 'COX6C', 'LSM4']",0.9930663776353466,0,0,8
23,Gastric acid production WP2596,0.1501024476907494,6.194207836456559,11.74692637252834,"['CCK', 'VIP']",0.9930663776353466,0,0,2
24,Monoamine Transport WP727,0.1501024476907494,6.194207836456559,11.74692637252834,"['ADORA2A', 'IL1R1']",0.9930663776353466,0,0,2
25,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.1501024476907494,6.194207836456559,11.74692637252834,"['MAP1LC3A', 'FTL']",0.9930663776353466,0,0,2
26,Overview of nanoparticle effects WP3287,0.1501024476907494,6.194207836456559,11.74692637252834,"['BAX', 'PTGS2']",0.9930663776353466,0,0,2
27,"Relationship between inflammation, COX-2 and EGFR WP4483",0.1501024476907494,6.194207836456559,11.74692637252834,"['PTGS2', 'HRAS']",0.9930663776353466,0,0,2
28,Ferroptosis WP4313,0.15538888040656118,2.480683760683761,4.618597550018518,"['MAP1LC3A', 'GPX4', 'SAT2', 'FTL']",0.9930663776353466,0,0,4
29,Proteasome Degradation WP183,0.15538888040656118,2.480683760683761,4.618597550018518,"['PSMB6', 'H2AFZ', 'HLA-B', 'PSMB10']",0.9930663776353466,0,0,4
30,Copper homeostasis WP3286,0.16073521878922484,3.098976109215017,5.664918632921895,"['SCO2', 'COX17', 'ATOX1']",0.9930663776353466,0,0,3
31,Eukaryotic Transcription Initiation WP405,0.16073521878922484,3.098976109215017,5.664918632921895,"['TAF13', 'POLR2I', 'POLR2K']",0.9930663776353466,0,0,3
32,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.16073521878922484,3.098976109215017,5.664918632921895,"['MAVS', 'TRADD', 'FADD']",0.9930663776353466,0,0,3
33,TNF-alpha signaling pathway WP231,0.21127191207037463,2.066096866096866,3.2119733869233666,"['TRADD', 'BAX', 'FADD', 'HRAS']",0.9930663776353466,0,0,4
34,mRNA Processing WP411,0.21127191207037463,2.066096866096866,3.2119733869233666,"['LSM7', 'SNRPE', 'SRSF9', 'LSM2']",0.9930663776353466,0,0,4
35,Leptin signaling pathway WP2034,0.23223655851586705,2.322952218430034,3.3915074003281847,"['RPS6', 'BAX', 'HRAS']",0.9930663776353466,0,0,3
36,Oxidative Damage WP3941,0.23223655851586705,2.322952218430034,3.3915074003281847,"['C1QB', 'C5AR1', 'CYCS']",0.9930663776353466,0,0,3
37,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.23223655851586705,2.322952218430034,3.3915074003281847,"['MAVS', 'TRADD', 'FADD']",0.9930663776353466,0,0,3
38,15q11.2 copy number variation syndrome WP4940,0.2446010976350461,inf,inf,['TUBGCP4'],0.9930663776353466,0,0,1
39,Serotonin Transporter Activity WP1455,0.2446010976350461,inf,inf,['IL1R1'],0.9930663776353466,0,0,1
40,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.2446010976350461,inf,inf,['IDH3B'],0.9930663776353466,0,0,1
41,Vitamin B12 Disorders WP4271,0.2446010976350461,inf,inf,['CUBN'],0.9930663776353466,0,0,1
42,EV release from cardiac cells and their functional effects WP3297,0.2446010976350461,inf,inf,['RGS16'],0.9930663776353466,0,0,1
43,Globo Sphingolipid Metabolism WP1424,0.2446010976350461,inf,inf,['FUT2'],0.9930663776353466,0,0,1
44,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.2446010976350461,inf,inf,['ELOB'],0.9930663776353466,0,0,1
45,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.2446010976350461,inf,inf,['MAP1LC3A'],0.9930663776353466,0,0,1
46,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.2446010976350461,inf,inf,['HRAS'],0.9930663776353466,0,0,1
47,Insulin signaling in adipocytes (diabetic condition) WP3635,0.2446010976350461,inf,inf,['RPS6'],0.9930663776353466,0,0,1
48,Insulin signaling in adipocytes (normal condition) WP3634,0.2446010976350461,inf,inf,['RPS6'],0.9930663776353466,0,0,1
49,LDLRAD4 and what we know about it WP4904,0.2446010976350461,inf,inf,['TGFBR2'],0.9930663776353466,0,0,1
50,Macrophage markers WP4146,0.2446010976350461,inf,inf,['CD74'],0.9930663776353466,0,0,1
51,Mitochondrial CII Assembly WP4920,0.2446010976350461,inf,inf,['SDHAF1'],0.9930663776353466,0,0,1
52,Nanoparticle triggered autophagic cell death WP2509,0.2446010976350461,inf,inf,['MAP1LC3A'],0.9930663776353466,0,0,1
53,Non-homologous end joining WP438,0.2446010976350461,inf,inf,['DCLRE1C'],0.9930663776353466,0,0,1
54,Phosphoinositides metabolism WP4971,0.2446010976350461,inf,inf,['PIP4P1'],0.9930663776353466,0,0,1
55,SARS coronavirus and innate immunity WP4912,0.2446010976350461,inf,inf,['MAVS'],0.9930663776353466,0,0,1
56,Apoptosis Modulation by HSP70 WP384,0.25254883789242333,3.0954003407155026,4.259737133849145,"['CYCS', 'FADD']",0.9930663776353466,0,0,2
57,BDNF-TrkB Signaling WP3676,0.25254883789242333,3.0954003407155026,4.259737133849145,"['HOMER1', 'HRAS']",0.9930663776353466,0,0,2
58,Type 2 papillary renal cell carcinoma WP4241,0.25254883789242333,3.0954003407155026,4.259737133849145,"['EPAS1', 'ELOB']",0.9930663776353466,0,0,2
59,White fat cell differentiation WP4149,0.25254883789242333,3.0954003407155026,4.259737133849145,"['DDIT3', 'NR2F2']",0.9930663776353466,0,0,2
60,GABA receptor Signaling WP4159,0.25254883789242333,3.0954003407155026,4.259737133849145,"['SLC32A1', 'AP2M1']",0.9930663776353466,0,0,2
61,Genes targeted by miRNAs in adipocytes WP1992,0.25254883789242333,3.0954003407155026,4.259737133849145,"['TMSB4X', 'ERG']",0.9930663776353466,0,0,2
62,Major receptors targeted by epinephrine and norepinephrine WP4589,0.25254883789242333,3.0954003407155026,4.259737133849145,"['ADRA1D', 'ADRA2A']",0.9930663776353466,0,0,2
63,miRNA regulation of p53 pathway in prostate cancer WP3982,0.25254883789242333,3.0954003407155026,4.259737133849145,"['CHEK2', 'BAX']",0.9930663776353466,0,0,2
64,SARS-CoV-2 mitochondrial interactions WP5038,0.25254883789242333,3.0954003407155026,4.259737133849145,"['NDUFB9', 'MAVS']",0.9930663776353466,0,0,2
65,Apoptosis Modulation and Signaling WP1772,0.26356338354429704,1.5497427101200687,2.0665220763863337,"['ENDOG', 'IL1R1', 'TRADD', 'CYCS', 'BAX', 'FADD']",0.9930663776353466,0,0,6
66,IL-18 signaling pathway WP4754,0.28772769944999793,1.2836909101774936,1.5991460568312368,"['ADAMTS5', 'CD81', 'TMSB4X', 'RGS16', 'COX17', 'CYCS', 'BAX', 'NDUFC1', 'FADD', 'LTB', 'PTGS2', 'RND2']",0.9930663776353466,0,0,12
67,16p11.2 proximal deletion syndrome WP4949,0.30790708561167324,1.8573378839590444,2.187864554809929,"['ASPHD1', 'SEZ6L2', 'CCT7']",0.9930663776353466,0,0,3
68,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.30790708561167324,1.8573378839590444,2.187864554809929,"['PPP1R14B', 'MAP1LC3A', 'DDIT3']",0.9930663776353466,0,0,3
69,Hepatitis B infection WP4666,0.3115457827844988,1.4297400712495052,1.6673757049002798,"['MAVS', 'CYCS', 'BAX', 'FADD', 'HRAS', 'TGFBR2']",0.9930663776353466,0,0,6
70,Integrated breast cancer pathway WP1984,0.3115457827844988,1.4297400712495052,1.6673757049002798,"['CHEK2', 'TRADD', 'BAX', 'FADD', 'FAU', 'TGFBR2']",0.9930663776353466,0,0,6
71,Apoptosis WP254,0.33436629629957687,1.547863247863248,1.6957123458784409,"['TRADD', 'CYCS', 'BAX', 'FADD']",0.9930663776353466,0,0,4
72,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.33436629629957687,1.547863247863248,1.6957123458784409,"['CYCS', 'BAX', 'PTGS2', 'TGFBR2']",0.9930663776353466,0,0,4
73,DNA Repair Pathways Full Network WP4946,0.33436629629957687,1.547863247863248,1.6957123458784409,"['POLD4', 'DCLRE1C', 'CENPX', 'APEX1']",0.9930663776353466,0,0,4
74,Head and Neck Squamous Cell Carcinoma WP4674,0.33436629629957687,1.547863247863248,1.6957123458784409,"['RPS6', 'FADD', 'HRAS', 'TGFBR2']",0.9930663776353466,0,0,4
75,Male infertility WP4673,0.33436629629957687,1.547863247863248,1.6957123458784409,"['HLA-DRA', 'PEX10', 'HORMAD1', 'TEX15']",0.9930663776353466,0,0,4
76,Gastrin signaling pathway WP4659,0.3501910457794403,1.4072229140722292,1.476565833147193,"['KAT5', 'ANXA2', 'RPS6', 'PTGS2', 'HRAS']",0.9930663776353466,0,0,5
77,DNA Replication WP466,0.35579072401098405,2.062464508801817,2.131376758651229,"['POLD4', 'GMNN']",0.9930663776353466,0,0,2
78,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.35579072401098405,2.062464508801817,2.131376758651229,"['HRAS', 'TGFBR2']",0.9930663776353466,0,0,2
79,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.35579072401098405,2.062464508801817,2.131376758651229,"['LDHA', 'RPS6']",0.9930663776353466,0,0,2
80,IL-2 signaling pathway WP49,0.35579072401098405,2.062464508801817,2.131376758651229,"['RPS6', 'HRAS']",0.9930663776353466,0,0,2
81,Interleukin-11 Signaling Pathway WP2332,0.35579072401098405,2.062464508801817,2.131376758651229,"['RPS6', 'HRAS']",0.9930663776353466,0,0,2
82,Kallmann's Syndrome WP5074,0.35579072401098405,2.062464508801817,2.131376758651229,"['TMEM98', 'CHD7']",0.9930663776353466,0,0,2
83,MET in type 1 papillary renal cell carcinoma WP4205,0.35579072401098405,2.062464508801817,2.131376758651229,"['RPL11', 'HRAS']",0.9930663776353466,0,0,2
84,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.35579072401098405,2.062464508801817,2.131376758651229,"['RAB13', 'FERMT3']",0.9930663776353466,0,0,2
85,PPAR signaling pathway WP3942,0.35579072401098405,2.062464508801817,2.131376758651229,"['FABP6', 'PCK2']",0.9930663776353466,0,0,2
86,Prostaglandin Synthesis and Regulation WP98,0.35579072401098405,2.062464508801817,2.131376758651229,"['ANXA2', 'PTGS2']",0.9930663776353466,0,0,2
87,Rett syndrome causing genes WP4312,0.35579072401098405,2.062464508801817,2.131376758651229,"['IMPDH2', 'TBL1X']",0.9930663776353466,0,0,2
88,Non-small cell lung cancer WP4255,0.3841661663989901,1.5469283276450512,1.4799155394426995,"['CYCS', 'BAX', 'HRAS']",0.9930663776353466,0,0,3
89,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.3841661663989901,1.5469283276450512,1.4799155394426995,"['LDHA', 'BAX', 'PTGS2']",0.9930663776353466,0,0,3
90,Serotonin and anxiety WP3947,0.42944921119747265,3.0918367346938775,2.6133805515333326,['CRH'],0.9930663776353466,0,0,1
91,Serotonin and anxiety-related events WP3944,0.42944921119747265,3.0918367346938775,2.6133805515333326,['CRH'],0.9930663776353466,0,0,1
92,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.42944921119747265,3.0918367346938775,2.6133805515333326,['HRAS'],0.9930663776353466,0,0,1
93,Splicing factor NOVA regulated synaptic proteins WP4148,0.42944921119747265,3.0918367346938775,2.6133805515333326,['NTNG1'],0.9930663776353466,0,0,1
94,Amyotrophic lateral sclerosis (ALS) WP2447,0.42944921119747265,3.0918367346938775,2.6133805515333326,['BAX'],0.9930663776353466,0,0,1
95,Aspirin and miRNAs WP4707,0.42944921119747265,3.0918367346938775,2.6133805515333326,['PTGS2'],0.9930663776353466,0,0,1
96,Biomarkers for pyrimidine metabolism disorders WP4584,0.42944921119747265,3.0918367346938775,2.6133805515333326,['NT5C'],0.9930663776353466,0,0,1
97,Canonical and non-canonical TGF-B signaling WP3874,0.42944921119747265,3.0918367346938775,2.6133805515333326,['TGFBR2'],0.9930663776353466,0,0,1
98,Transcription factor regulation in adipogenesis WP3599,0.42944921119747265,3.0918367346938775,2.6133805515333326,['PCK2'],0.9930663776353466,0,0,1
99,Transcriptional cascade regulating adipogenesis WP4211,0.42944921119747265,3.0918367346938775,2.6133805515333326,['DDIT3'],0.9930663776353466,0,0,1
100,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.42944921119747265,3.0918367346938775,2.6133805515333326,['CCK'],0.9930663776353466,0,0,1
101,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.42944921119747265,3.0918367346938775,2.6133805515333326,['MAVS'],0.9930663776353466,0,0,1
102,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.42944921119747265,3.0918367346938775,2.6133805515333326,['SYTL3'],0.9930663776353466,0,0,1
103,Disruption of postsynaptic signaling by CNV WP4875,0.42944921119747265,3.0918367346938775,2.6133805515333326,['HOMER1'],0.9930663776353466,0,0,1
104,Dual hijack model of Vif in HIV infection WP3300,0.42944921119747265,3.0918367346938775,2.6133805515333326,['ELOB'],0.9930663776353466,0,0,1
105,Ebstein-Barr virus LMP1 signaling WP262,0.42944921119747265,3.0918367346938775,2.6133805515333326,['TRADD'],0.9930663776353466,0,0,1
106,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.42944921119747265,3.0918367346938775,2.6133805515333326,['PTGS2'],0.9930663776353466,0,0,1
107,Energy Metabolism WP1541,0.42944921119747265,3.0918367346938775,2.6133805515333326,['UCP3'],0.9930663776353466,0,0,1
108,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.42944921119747265,3.0918367346938775,2.6133805515333326,['MAFF'],0.9930663776353466,0,0,1
109,Fatty acid transporters WP5061,0.42944921119747265,3.0918367346938775,2.6133805515333326,['FABP6'],0.9930663776353466,0,0,1
110,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.42944921119747265,3.0918367346938775,2.6133805515333326,['H2AFZ'],0.9930663776353466,0,0,1
111,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.42944921119747265,3.0918367346938775,2.6133805515333326,['RPS6'],0.9930663776353466,0,0,1
112,Glutathione metabolism WP100,0.42944921119747265,3.0918367346938775,2.6133805515333326,['GPX4'],0.9930663776353466,0,0,1
113,Homologous recombination WP186,0.42944921119747265,3.0918367346938775,2.6133805515333326,['POLD4'],0.9930663776353466,0,0,1
114,MAPK Cascade WP422,0.42944921119747265,3.0918367346938775,2.6133805515333326,['HRAS'],0.9930663776353466,0,0,1
115,Metabolism of alpha-linolenic acid WP4586,0.42944921119747265,3.0918367346938775,2.6133805515333326,['PTGS2'],0.9930663776353466,0,0,1
116,MTHFR deficiency WP4288,0.42944921119747265,3.0918367346938775,2.6133805515333326,['CYCS'],0.9930663776353466,0,0,1
117,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.42944921119747265,3.0918367346938775,2.6133805515333326,['SCO2'],0.9930663776353466,0,0,1
118,Nuclear receptors WP170,0.42944921119747265,3.0918367346938775,2.6133805515333326,['NR2F2'],0.9930663776353466,0,0,1
119,Nucleotide GPCRs WP80,0.42944921119747265,3.0918367346938775,2.6133805515333326,['ADORA2A'],0.9930663776353466,0,0,1
120,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.42944921119747265,3.0918367346938775,2.6133805515333326,['MAVS'],0.9930663776353466,0,0,1
121,Peroxiredoxin 2 induced ovarian failure WP4873,0.42944921119747265,3.0918367346938775,2.6133805515333326,['BAX'],0.9930663776353466,0,0,1
122,Fas ligand pathway and stress induction of heat shock proteins WP314,0.453318432519974,1.5459965928449744,1.223131373855532,"['CYCS', 'FADD']",0.9930663776353466,0,0,2
123,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.453318432519974,1.5459965928449744,1.223131373855532,"['BAX', 'FADD']",0.9930663776353466,0,0,2
124,Integrated Cancer Pathway WP1971,0.453318432519974,1.5459965928449744,1.223131373855532,"['CHEK2', 'BAX']",0.9930663776353466,0,0,2
125,Pathways affected in adenoid cystic carcinoma WP3651,0.453318432519974,1.5459965928449744,1.223131373855532,"['CHEK2', 'HRAS']",0.9930663776353466,0,0,2
126,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.4582636723721869,1.3252072159921988,1.0340731803907104,"['APEX1', 'RPS6', 'HRAS']",0.9930663776353466,0,0,3
127,Endometrial cancer WP4155,0.4582636723721869,1.3252072159921988,1.0340731803907104,"['BAX', 'FGF1', 'HRAS']",0.9930663776353466,0,0,3
128,Alzheimer's disease WP2059,0.5282515127364138,1.1589163822525597,0.7396004540617117,"['ATP5MD', 'CYCS', 'FADD']",0.9930663776353466,0,0,3
129,DNA damage response WP707,0.5282515127364138,1.1589163822525597,0.7396004540617117,"['CHEK2', 'CYCS', 'BAX']",0.9930663776353466,0,0,3
130,miRNA regulation of DNA damage response WP1530,0.5282515127364138,1.1589163822525597,0.7396004540617117,"['CHEK2', 'CYCS', 'BAX']",0.9930663776353466,0,0,3
131,Aryl Hydrocarbon Receptor Netpath WP2586,0.5417511271743528,1.2361158432708688,0.7576754235928447,"['PTGS2', 'HRAS']",0.9930663776353466,0,0,2
132,Canonical and non-canonical Notch signaling WP3845,0.5417511271743528,1.2361158432708688,0.7576754235928447,"['MAML2', 'DLK2']",0.9930663776353466,0,0,2
133,Computational Model of Aerobic Glycolysis WP4629,0.5417511271743528,1.2361158432708688,0.7576754235928447,"['LDHA', 'PFKM']",0.9930663776353466,0,0,2
134,Kit receptor signaling pathway WP304,0.5417511271743528,1.2361158432708688,0.7576754235928447,"['RPS6', 'HRAS']",0.9930663776353466,0,0,2
135,Modulators of TCR signaling and T cell activation WP5072,0.5417511271743528,1.2361158432708688,0.7576754235928447,"['NDUFB10', 'ELOB']",0.9930663776353466,0,0,2
136,VEGFA-VEGFR2 Signaling Pathway WP3888,0.5569123382030767,0.992431823867901,0.5809174210067981,"['SET', 'RPS6', 'PTGS2', 'RPL10A', 'RPL7', 'LDHA', 'RPL18A', 'TMSB4X', 'MMRN2', 'RPLP2', 'CYCS', 'RPL27', 'RPL26', 'ERG', 'FADD', 'CCT7', 'HRAS', 'CGNL1']",0.9930663776353466,0,0,18
137,16p11.2 distal deletion syndrome WP4950,0.5691224692944381,1.5450680272108843,0.8708924756286515,['CD81'],0.9930663776353466,0,0,1
138,Signal transduction through IL1R WP4496,0.5691224692944381,1.5450680272108843,0.8708924756286515,['IL1R1'],0.9930663776353466,0,0,1
139,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.5691224692944381,1.5450680272108843,0.8708924756286515,['VIP'],0.9930663776353466,0,0,1
140,Vitamin D-sensitive calcium signaling in depression WP4698,0.5691224692944381,1.5450680272108843,0.8708924756286515,['GPX4'],0.9930663776353466,0,0,1
141,EDA signaling in hair follicle development WP3930,0.5691224692944381,1.5450680272108843,0.8708924756286515,['LTB'],0.9930663776353466,0,0,1
142,Eicosanoid Synthesis WP167,0.5691224692944381,1.5450680272108843,0.8708924756286515,['PTGS2'],0.9930663776353466,0,0,1
143,Glycosylation and related congenital defects WP4521,0.5691224692944381,1.5450680272108843,0.8708924756286515,['DPM3'],0.9930663776353466,0,0,1
144,Histone Modifications WP2369,0.5691224692944381,1.5450680272108843,0.8708924756286515,['SET'],0.9930663776353466,0,0,1
145,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.5691224692944381,1.5450680272108843,0.8708924756286515,['MAVS'],0.9930663776353466,0,0,1
146,IL1 and megakaryocytes in obesity WP2865,0.5691224692944381,1.5450680272108843,0.8708924756286515,['IL1R1'],0.9930663776353466,0,0,1
147,IL17 signaling pathway WP2112,0.5691224692944381,1.5450680272108843,0.8708924756286515,['IL17RE'],0.9930663776353466,0,0,1
148,Interferon type I signaling pathways WP585,0.5691224692944381,1.5450680272108843,0.8708924756286515,['RPS6'],0.9930663776353466,0,0,1
149,Joubert Syndrome WP4656,0.5691224692944381,1.5450680272108843,0.8708924756286515,['KAT5'],0.9930663776353466,0,0,1
150,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.5691224692944381,1.5450680272108843,0.8708924756286515,['BAX'],0.9930663776353466,0,0,1
151,Nanoparticle-mediated activation of receptor signaling WP2643,0.5691224692944381,1.5450680272108843,0.8708924756286515,['HRAS'],0.9930663776353466,0,0,1
152,NO/cGMP/PKG mediated Neuroprotection WP4008,0.5691224692944381,1.5450680272108843,0.8708924756286515,['CYCS'],0.9930663776353466,0,0,1
153,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.5691224692944381,1.5450680272108843,0.8708924756286515,['HRAS'],0.9930663776353466,0,0,1
154,Purinergic signaling WP4900,0.5691224692944381,1.5450680272108843,0.8708924756286515,['ADORA2A'],0.9930663776353466,0,0,1
155,Pyrimidine metabolism and related diseases WP4225,0.5691224692944381,1.5450680272108843,0.8708924756286515,['NT5C'],0.9930663776353466,0,0,1
156,RalA downstream regulated genes WP2290,0.5691224692944381,1.5450680272108843,0.8708924756286515,['HRAS'],0.9930663776353466,0,0,1
157,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.5691224692944381,1.5450680272108843,0.8708924756286515,['ANAPC11'],0.9930663776353466,0,0,1
158,"GPCRs, Class A Rhodopsin-like WP455",0.5791632696116084,0.9880895008605852,0.5396656881411462,"['NPFFR1', 'ADORA2A', 'GPR22', 'NPY1R', 'ADRA1D', 'OR6A2', 'MCHR1', 'ADRA2A']",0.9930663776353466,0,0,8
159,Acute viral myocarditis WP4298,0.5928798732914197,1.0295790671217293,0.5382263309736068,"['ENDOG', 'CYCS', 'BAX']",0.9930663776353466,0,0,3
160,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.5928798732914197,1.0295790671217293,0.5382263309736068,"['RPS6', 'BAX', 'HRAS']",0.9930663776353466,0,0,3
161,Genotoxicity pathway WP4286,0.5928798732914197,1.0295790671217293,0.5382263309736068,"['RPS27', 'BLOC1S2', 'TRIAP1']",0.9930663776353466,0,0,3
162,Spinal Cord Injury WP2431,0.598521585206124,0.974993229213686,0.5004568965038525,"['C1QB', 'IL1R1', 'APEX1', 'OMG', 'LTB', 'PTGS2']",0.9930663776353466,0,0,6
163,Synaptic Vesicle Pathway WP2267,0.6196990790157484,1.0295286768881318,0.4926513753120322,"['SLC32A1', 'AP2M1']",0.9930663776353466,0,0,2
164,Base Excision Repair WP4752,0.6196990790157484,1.0295286768881318,0.4926513753120322,"['POLD4', 'APEX1']",0.9930663776353466,0,0,2
165,Fragile X Syndrome  WP4549,0.6196990790157484,1.0295286768881318,0.4926513753120322,"['HOMER1', 'AP2M1']",0.9930663776353466,0,0,2
166,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.6196990790157484,1.0295286768881318,0.4926513753120322,"['IFITM3', 'DDIT3']",0.9930663776353466,0,0,2
167,MECP2 and Associated Rett Syndrome WP3584,0.6196990790157484,1.0295286768881318,0.4926513753120322,"['SST', 'RPS6']",0.9930663776353466,0,0,2
168,Monoamine GPCRs WP58,0.6196990790157484,1.0295286768881318,0.4926513753120322,"['ADRA1D', 'ADRA2A']",0.9930663776353466,0,0,2
169,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.6196990790157484,1.0295286768881318,0.4926513753120322,"['IFI27L2', 'HRAS']",0.9930663776353466,0,0,2
170,Prolactin Signaling Pathway WP2037,0.6196990790157484,1.0295286768881318,0.4926513753120322,"['RPS6', 'HRAS']",0.9930663776353466,0,0,2
171,Androgen receptor signaling pathway WP138,0.6514661745438838,0.9261092150170649,0.39686539957375533,"['KAT5', 'BAG1', 'STUB1']",0.9930663776353466,0,0,3
172,DNA damage response (only ATM dependent) WP710,0.6514661745438838,0.9261092150170649,0.39686539957375533,"['BAX', 'HRAS', 'PCK2']",0.9930663776353466,0,0,3
173,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.6746469023817886,1.0294784580498866,0.4051675464456552,['EPAS1'],0.9930663776353466,0,0,1
174,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.6746469023817886,1.0294784580498866,0.4051675464456552,['IL1R1'],0.9930663776353466,0,0,1
175,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.6746469023817886,1.0294784580498866,0.4051675464456552,['SST'],0.9930663776353466,0,0,1
176,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.6746469023817886,1.0294784580498866,0.4051675464456552,['RPS6'],0.9930663776353466,0,0,1
177,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.6746469023817886,1.0294784580498866,0.4051675464456552,['FADD'],0.9930663776353466,0,0,1
178,Cannabinoid receptor signaling WP3869,0.6746469023817886,1.0294784580498866,0.4051675464456552,['ADORA2A'],0.9930663776353466,0,0,1
179,TP53 network WP1742,0.6746469023817886,1.0294784580498866,0.4051675464456552,['BAX'],0.9930663776353466,0,0,1
180,Type II interferon signaling (IFNG) WP619,0.6746469023817886,1.0294784580498866,0.4051675464456552,['HLA-B'],0.9930663776353466,0,0,1
181,Endothelin Pathways WP2197,0.6746469023817886,1.0294784580498866,0.4051675464456552,['NPY1R'],0.9930663776353466,0,0,1
182,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.6746469023817886,1.0294784580498866,0.4051675464456552,['HRAS'],0.9930663776353466,0,0,1
183,ERK Pathway in Huntington's Disease WP3853,0.6746469023817886,1.0294784580498866,0.4051675464456552,['HRAS'],0.9930663776353466,0,0,1
184,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.6746469023817886,1.0294784580498866,0.4051675464456552,['CD81'],0.9930663776353466,0,0,1
185,Glycosaminoglycan degradation WP4815,0.6746469023817886,1.0294784580498866,0.4051675464456552,['SGSH'],0.9930663776353466,0,0,1
186,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.6746469023817886,1.0294784580498866,0.4051675464456552,['FGF1'],0.9930663776353466,0,0,1
187,HIF1A and PPARG regulation of glycolysis WP2456,0.6746469023817886,1.0294784580498866,0.4051675464456552,['LDHA'],0.9930663776353466,0,0,1
188,IL-1 signaling pathway WP195,0.6746469023817886,1.0294784580498866,0.4051675464456552,['IL1R1'],0.9930663776353466,0,0,1
189,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.6746469023817886,1.0294784580498866,0.4051675464456552,['TGFBR2'],0.9930663776353466,0,0,1
190,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.6746469023817886,1.0294784580498866,0.4051675464456552,['HRAS'],0.9930663776353466,0,0,1
191,Mammalian disorder of sexual development WP4842,0.6746469023817886,1.0294784580498866,0.4051675464456552,['EMX2'],0.9930663776353466,0,0,1
192,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.6746469023817886,1.0294784580498866,0.4051675464456552,['ANXA2'],0.9930663776353466,0,0,1
193,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.6746469023817886,1.0294784580498866,0.4051675464456552,['VEGFB'],0.9930663776353466,0,0,1
194,miR-509-3p alteration of YAP1/ECM axis WP3967,0.6746469023817886,1.0294784580498866,0.4051675464456552,['COL5A1'],0.9930663776353466,0,0,1
195,miRNA targets in ECM and membrane receptors WP2911,0.6746469023817886,1.0294784580498866,0.4051675464456552,['COL5A1'],0.9930663776353466,0,0,1
196,Nucleotide metabolism WP404,0.6746469023817886,1.0294784580498866,0.4051675464456552,['NME2'],0.9930663776353466,0,0,1
197,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.6746469023817886,1.0294784580498866,0.4051675464456552,['HLA-DRA'],0.9930663776353466,0,0,1
198,PDGF Pathway WP2526,0.6746469023817886,1.0294784580498866,0.4051675464456552,['HRAS'],0.9930663776353466,0,0,1
199,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.6746469023817886,1.0294784580498866,0.4051675464456552,['PTGS2'],0.9930663776353466,0,0,1
200,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.6746469023817886,1.0294784580498866,0.4051675464456552,['BAX'],0.9930663776353466,0,0,1
201,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.6746469023817886,1.0294784580498866,0.4051675464456552,['BAX'],0.9930663776353466,0,0,1
202,Allograft Rejection WP2328,0.6764364168891801,0.8815628815628815,0.3446177619285577,"['C1QB', 'COL5A1', 'HLA-B', 'HLA-DRA']",0.9930663776353466,0,0,4
203,Thermogenesis WP4321,0.6869941300534186,0.8819664151861767,0.33111623771204624,"['RPS6', 'HRAS']",0.9930663776353466,0,0,2
204,Complement and Coagulation Cascades WP558,0.6869941300534186,0.8819664151861767,0.33111623771204624,"['C1QB', 'C5AR1']",0.9930663776353466,0,0,2
205,Melanoma WP4685,0.6869941300534186,0.8819664151861767,0.33111623771204624,"['BAX', 'HRAS']",0.9930663776353466,0,0,2
206,Phosphodiesterases in neuronal function WP4222,0.6869941300534186,0.8819664151861767,0.33111623771204624,"['PDE10A', 'ADORA2A']",0.9930663776353466,0,0,2
207,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.6869941300534186,0.8819664151861767,0.33111623771204624,"['BAX', 'HRAS']",0.9930663776353466,0,0,2
208,NRF2 pathway WP2884,0.6974686925820722,0.8566400304414004,0.30864539113263156,"['GSTP1', 'MAFF', 'SLC5A3', 'FTL', 'TGFBR2']",0.9930663776353466,0,0,5
209,22q11.2 copy number variation syndrome WP4657,0.7037635279034424,0.8414520632950667,0.295612945310414,"['RANBP1', 'MRPL40', 'THAP7']",0.9930663776353466,0,0,3
210,Small cell lung cancer WP4658,0.7037635279034424,0.8414520632950667,0.295612945310414,"['CYCS', 'BAX', 'PTGS2']",0.9930663776353466,0,0,3
211,Complement system WP2806,0.7037635279034424,0.8414520632950667,0.295612945310414,"['FKBP2', 'RPS19', 'C5AR1']",0.9930663776353466,0,0,3
212,Regulation of Actin Cytoskeleton WP51,0.7037635279034424,0.8414520632950667,0.295612945310414,"['DIAPH3', 'TMSB4X', 'FGF1']",0.9930663776353466,0,0,3
213,Sleep regulation WP3591,0.7441766743121155,0.7712947189097104,0.227899700696231,"['ADORA2A', 'CRH']",0.9930663776353466,0,0,2
214,Amino Acid metabolism WP3925,0.7441766743121155,0.7712947189097104,0.227899700696231,"['LDHA', 'MARS2']",0.9930663776353466,0,0,2
215,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.7441766743121155,0.7712947189097104,0.227899700696231,"['HRAS', 'TGFBR2']",0.9930663776353466,0,0,2
216,TGF-beta Receptor Signaling WP560,0.7441766743121155,0.7712947189097104,0.227899700696231,"['HRAS', 'TGFBR2']",0.9930663776353466,0,0,2
217,Ectoderm Differentiation WP2858,0.7441766743121155,0.7712947189097104,0.227899700696231,"['NR2F2', 'TBL1X']",0.9930663776353466,0,0,2
218,"GPCRs, Other WP117",0.7441766743121155,0.7712947189097104,0.227899700696231,"['ADORA2A', 'ADRA1D']",0.9930663776353466,0,0,2
219,ATM Signaling Pathway WP2516,0.754360840381049,0.7716836734693877,0.21752563350841012,['CHEK2'],0.9930663776353466,0,0,1
220,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.754360840381049,0.7716836734693877,0.21752563350841012,['RPS6'],0.9930663776353466,0,0,1
221,Vitamin A and carotenoid metabolism WP716,0.754360840381049,0.7716836734693877,0.21752563350841012,['RBP4'],0.9930663776353466,0,0,1
222,Cytokines and Inflammatory Response WP530,0.754360840381049,0.7716836734693877,0.21752563350841012,['HLA-DRA'],0.9930663776353466,0,0,1
223,GDNF/RET signaling axis WP4830,0.754360840381049,0.7716836734693877,0.21752563350841012,['SALL1'],0.9930663776353466,0,0,1
224,Genes related to primary cilium development (based on CRISPR) WP4536,0.754360840381049,0.7716836734693877,0.21752563350841012,['TTC30B'],0.9930663776353466,0,0,1
225,Glycolysis in senescence WP5049,0.754360840381049,0.7716836734693877,0.21752563350841012,['LDHA'],0.9930663776353466,0,0,1
226,"GPCRs, Class B Secretin-like WP334",0.754360840381049,0.7716836734693877,0.21752563350841012,['ADGRL4'],0.9930663776353466,0,0,1
227,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.754360840381049,0.7716836734693877,0.21752563350841012,['TGFBR2'],0.9930663776353466,0,0,1
228,IL-5 signaling pathway WP127,0.754360840381049,0.7716836734693877,0.21752563350841012,['RPS6'],0.9930663776353466,0,0,1
229,Microglia Pathogen Phagocytosis Pathway WP3937,0.754360840381049,0.7716836734693877,0.21752563350841012,['C1QB'],0.9930663776353466,0,0,1
230,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.754360840381049,0.7716836734693877,0.21752563350841012,['OMG'],0.9930663776353466,0,0,1
231,PDGFR-beta pathway WP3972,0.754360840381049,0.7716836734693877,0.21752563350841012,['HRAS'],0.9930663776353466,0,0,1
232,Myometrial relaxation and contraction pathways WP289,0.7693380974084598,0.7701198630136986,0.20194448667696985,"['IGFBP5', 'RGS16', 'MAFF', 'CRH', 'IGFBP6']",0.9930663776353466,0,0,5
233,MAPK Signaling Pathway WP382,0.7795677280815174,0.7697255574614065,0.19167375441715082,"['DUSP4', 'IL1R1', 'DDIT3', 'FGF1', 'HRAS', 'TGFBR2']",0.9930663776353466,0,0,6
234,Ciliopathies WP4803,0.7899902748435078,0.7112102914150695,0.1676569048000492,"['CCDC65', 'AK7', 'CCDC28B']",0.9930663776353466,0,0,3
235,Ebola Virus Pathway on Host WP4217,0.7899902748435078,0.7112102914150695,0.1676569048000492,"['HLA-B', 'VPS11', 'HLA-DRA']",0.9930663776353466,0,0,3
236,Endoderm differentiation WP2853,0.7899902748435078,0.7112102914150695,0.1676569048000492,"['DUSP4', 'TCEAL2', 'NME1']",0.9930663776353466,0,0,3
237,7q11.23 copy number variation syndrome WP4932,0.7921599711734696,0.6852167329169033,0.15964996479403443,"['ATP5F1E', 'ATP5MC1']",0.9930663776353466,0,0,2
238,B Cell Receptor Signaling Pathway WP23,0.7921599711734696,0.6852167329169033,0.15964996479403443,"['CD81', 'HRAS']",0.9930663776353466,0,0,2
239,Pancreatic adenocarcinoma pathway WP4263,0.7921599711734696,0.6852167329169033,0.15964996479403443,"['BAX', 'TGFBR2']",0.9930663776353466,0,0,2
240,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.8145034546607027,0.7423865386894182,0.1523203529463106,"['COL5A1', 'EPAS1', 'COL11A1', 'RPS6', 'VEGFB', 'FGF1', 'HRAS']",0.9930663776353466,0,0,7
241,Signaling of Hepatocyte Growth Factor Receptor WP313,0.8145692167658638,0.6170068027210884,0.12654554938672466,['HRAS'],0.9930663776353466,0,0,1
242,Alpha 6 Beta 4 signaling pathway WP244,0.8145692167658638,0.6170068027210884,0.12654554938672466,['HRAS'],0.9930663776353466,0,0,1
243,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.8145692167658638,0.6170068027210884,0.12654554938672466,['HRAS'],0.9930663776353466,0,0,1
244,Translation Factors WP107,0.8145692167658638,0.6170068027210884,0.12654554938672466,['EEF1B2'],0.9930663776353466,0,0,1
245,Complement Activation WP545,0.8145692167658638,0.6170068027210884,0.12654554938672466,['C1QB'],0.9930663776353466,0,0,1
246,Vitamin B12 metabolism WP1533,0.8145692167658638,0.6170068027210884,0.12654554938672466,['CUBN'],0.9930663776353466,0,0,1
247,Cori Cycle WP1946,0.8145692167658638,0.6170068027210884,0.12654554938672466,['LDHA'],0.9930663776353466,0,0,1
248,DNA Mismatch Repair WP531,0.8145692167658638,0.6170068027210884,0.12654554938672466,['POLD4'],0.9930663776353466,0,0,1
249,Hepatitis C and Hepatocellular Carcinoma WP3646,0.8145692167658638,0.6170068027210884,0.12654554938672466,['PTGS2'],0.9930663776353466,0,0,1
250,Hypertrophy Model WP516,0.8145692167658638,0.6170068027210884,0.12654554938672466,['IL1R1'],0.9930663776353466,0,0,1
251,IL-6 signaling pathway WP364,0.8145692167658638,0.6170068027210884,0.12654554938672466,['VIP'],0.9930663776353466,0,0,1
252,Integrin-mediated Cell Adhesion WP185,0.8145692167658638,0.6170068027210884,0.12654554938672466,['HRAS'],0.9930663776353466,0,0,1
253,Nephrotic syndrome WP4758,0.8145692167658638,0.6170068027210884,0.12654554938672466,['CUBN'],0.9930663776353466,0,0,1
254,Nucleotide Excision Repair WP4753,0.8145692167658638,0.6170068027210884,0.12654554938672466,['POLD4'],0.9930663776353466,0,0,1
255,One-carbon metabolism and related pathways WP3940,0.8145692167658638,0.6170068027210884,0.12654554938672466,['GPX4'],0.9930663776353466,0,0,1
256,EGF/EGFR signaling pathway WP437,0.8246330169763108,0.6600438810336421,0.12726756188470337,"['NDUFA13', 'HRAS', 'AP2M1']",0.9930663776353466,0,0,3
257,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.8320159172282745,0.6163543441226575,0.11334984874665796,"['RPS6', 'HRAS']",0.9930663776353466,0,0,2
258,Exercise-induced Circadian Regulation WP410,0.8320159172282745,0.6163543441226575,0.11334984874665796,"['GSTP1', 'UCP3']",0.9930663776353466,0,0,2
259,Glycolysis and Gluconeogenesis WP534,0.8320159172282745,0.6163543441226575,0.11334984874665796,"['LDHA', 'PFKM']",0.9930663776353466,0,0,2
260,Peptide GPCRs WP24,0.8320159172282745,0.6163543441226575,0.11334984874665796,"['C5AR1', 'NPY1R']",0.9930663776353466,0,0,2
261,Circadian rhythm related genes WP3594,0.8511937923051444,0.6477732793522267,0.10436628553583527,"['HOMER1', 'ADORA2A', 'CRH', 'RPS27A']",0.9930663776353466,0,0,4
262,Senescence and Autophagy in Cancer WP615,0.8542722776445378,0.6156996587030716,0.09697596544234635,"['MAP1LC3A', 'IGFBP5', 'HRAS']",0.9930663776353466,0,0,3
263,AGE/RAGE pathway WP2324,0.8600387943383999,0.5138888888888888,0.07748302637609326,['CYCS'],0.9930663776353466,0,0,1
264,Toll-like Receptor Signaling Pathway WP75,0.8600387943383999,0.5138888888888888,0.07748302637609326,['FADD'],0.9930663776353466,0,0,1
265,Unfolded protein response WP4925,0.8600387943383999,0.5138888888888888,0.07748302637609326,['DDIT3'],0.9930663776353466,0,0,1
266,DNA IR-damage and cellular response via ATR WP4016,0.8600387943383999,0.5138888888888888,0.07748302637609326,['CHEK2'],0.9930663776353466,0,0,1
267,Folate Metabolism WP176,0.8600387943383999,0.5138888888888888,0.07748302637609326,['GPX4'],0.9930663776353466,0,0,1
268,G Protein Signaling Pathways WP35,0.8600387943383999,0.5138888888888888,0.07748302637609326,['HRAS'],0.9930663776353466,0,0,1
269,Heart Development WP1591,0.8600387943383999,0.5138888888888888,0.07748302637609326,['VEGFB'],0.9930663776353466,0,0,1
270,IL-3 signaling pathway WP286,0.8600387943383999,0.5138888888888888,0.07748302637609326,['HRAS'],0.9930663776353466,0,0,1
271,Lung fibrosis WP3624,0.8600387943383999,0.5138888888888888,0.07748302637609326,['FGF1'],0.9930663776353466,0,0,1
272,Notch Signaling Pathway Netpath WP61,0.8600387943383999,0.5138888888888888,0.07748302637609326,['MAML2'],0.9930663776353466,0,0,1
273,p53 transcriptional gene network WP4963,0.8600387943383999,0.5138888888888888,0.07748302637609326,['BAX'],0.9930663776353466,0,0,1
274,Parkinson's disease pathway WP2371,0.8600387943383999,0.5138888888888888,0.07748302637609326,['CYCS'],0.9930663776353466,0,0,1
275,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.8600387943383999,0.5138888888888888,0.07748302637609326,['GSTP1'],0.9930663776353466,0,0,1
276,Photodynamic therapy-induced unfolded protein response WP3613,0.8600387943383999,0.5138888888888888,0.07748302637609326,['DDIT3'],0.9930663776353466,0,0,1
277,Pre-implantation embryo WP3527,0.8600387943383999,0.5138888888888888,0.07748302637609326,['DDIT3'],0.9930663776353466,0,0,1
278,Retinoblastoma gene in cancer WP2446,0.8600387943383999,0.5138888888888888,0.07748302637609326,['H2AFZ'],0.9930663776353466,0,0,1
279,Adipogenesis WP236,0.8794408337105157,0.5768984641638225,0.07411356285660249,"['EPAS1', 'DDIT3', 'PCK2']",0.9936401987715706,0,0,3
280,Cell cycle WP179,0.891689585848469,0.513060760931289,0.05881585157455884,"['CHEK2', 'ANAPC11']",0.9936401987715706,0,0,2
281,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.8943729371758153,0.4402332361516035,0.049144308170696,['TMSB4X'],0.9936401987715706,0,0,1
282,Bladder cancer WP2828,0.8943729371758153,0.4402332361516035,0.049144308170696,['HRAS'],0.9936401987715706,0,0,1
283,Development of ureteric collection system WP5053,0.8943729371758153,0.4402332361516035,0.049144308170696,['SALL1'],0.9936401987715706,0,0,1
284,Differentiation Pathway WP2848,0.8943729371758153,0.4402332361516035,0.049144308170696,['FGF1'],0.9936401987715706,0,0,1
285,ErbB signaling pathway WP673,0.8943729371758153,0.4402332361516035,0.049144308170696,['HRAS'],0.9936401987715706,0,0,1
286,Genes controlling nephrogenesis WP4823,0.8943729371758153,0.4402332361516035,0.049144308170696,['EMX2'],0.9936401987715706,0,0,1
287,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.8943729371758153,0.4402332361516035,0.049144308170696,['NDUFA13'],0.9936401987715706,0,0,1
288,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9135121762554157,0.4733324597038396,0.04281697934159089,"['HRAS', 'TGFBR2']",0.9936401987715706,0,0,2
289,ESC Pluripotency Pathways WP3931,0.9135121762554157,0.4733324597038396,0.04281697934159089,"['FGF1', 'HRAS']",0.9936401987715706,0,0,2
290,Oncostatin M Signaling Pathway WP2374,0.9135121762554157,0.4733324597038396,0.04281697934159089,"['RPS6', 'HRAS']",0.9936401987715706,0,0,2
291,Pathways in clear cell renal cell carcinoma WP4018,0.9135121762554157,0.4733324597038396,0.04281697934159089,"['LDHA', 'PFKM']",0.9936401987715706,0,0,2
292,Proximal tubule transport WP4917,0.9135121762554157,0.4733324597038396,0.04281697934159089,"['SLC7A9', 'SLC26A6']",0.9936401987715706,0,0,2
293,Breast cancer pathway WP4262,0.9184704554177987,0.5122298065984073,0.04356286100074627,"['BAX', 'FGF1', 'HRAS']",0.9936401987715706,0,0,3
294,Aryl Hydrocarbon Receptor Pathway WP2873,0.9202951884311195,0.38499149659863946,0.03197770301438673,['BAX'],0.9936401987715706,0,0,1
295,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9202951884311195,0.38499149659863946,0.03197770301438673,['ADAMTS5'],0.9936401987715706,0,0,1
296,Endochondral Ossification WP474,0.9202951884311195,0.38499149659863946,0.03197770301438673,['ADAMTS5'],0.9936401987715706,0,0,1
297,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.9202951884311195,0.38499149659863946,0.03197770301438673,['BAX'],0.9936401987715706,0,0,1
298,Ras signaling WP4223,0.9311580910273939,0.4392796300803115,0.03133215042241589,"['RASAL1', 'HRAS']",0.9936401987715706,0,0,2
299,Chemokine signaling pathway WP3929,0.9398638158959467,0.3420256991685563,0.02121253336460872,['HRAS'],0.9936401987715706,0,0,1
300,Metabolic reprogramming in colon cancer WP4290,0.9398638158959467,0.3420256991685563,0.02121253336460872,['LDHA'],0.9936401987715706,0,0,1
301,Regulation of toll-like receptor signaling pathway WP1449,0.9398638158959467,0.3420256991685563,0.02121253336460872,['FADD'],0.9936401987715706,0,0,1
302,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.954634107849809,0.3076530612244898,0.014283453300767916,['RBP4'],0.9936401987715706,0,0,1
303,Glioblastoma signaling pathways WP2261,0.954634107849809,0.3076530612244898,0.014283453300767916,['HRAS'],0.9936401987715706,0,0,1
304,Glucocorticoid Receptor Pathway WP2880,0.954634107849809,0.3076530612244898,0.014283453300767916,['PTGS2'],0.9936401987715706,0,0,1
305,Mesodermal commitment pathway WP2857,0.954634107849809,0.3076530612244898,0.014283453300767916,['RPL38'],0.9936401987715706,0,0,1
306,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9567474336511235,0.38394378194207834,0.01697639569522249,"['RPS6', 'HRAS']",0.9936401987715706,0,0,2
307,Nuclear Receptors Meta-Pathway WP2882,0.9628628443051466,0.5349226804123711,0.020243775872568346,"['GSTP1', 'MAFF', 'BAX', 'PTGS2', 'SLC5A3', 'FTL', 'TGFBR2']",0.9936401987715706,0,0,7
308,Vitamin D Receptor Pathway WP2877,0.9641813268866436,0.41816630468507604,0.015252993830903549,"['ADAMTS5', 'IGFBP5', 'ZNF257']",0.9936401987715706,0,0,3
309,Metapathway biotransformation Phase I and II WP702,0.9641813268866436,0.41816630468507604,0.015252993830903549,"['GPX4', 'GSTP1', 'GAL3ST3']",0.9936401987715706,0,0,3
310,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.9657811277779753,0.2795299938157081,0.009732688250419171,['CARD14'],0.9936401987715706,0,0,1
311,T-cell receptor (TCR) signaling pathway WP69,0.9657811277779753,0.2795299938157081,0.009732688250419171,['HRAS'],0.9936401987715706,0,0,1
312,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.9657811277779753,0.2795299938157081,0.009732688250419171,['STUB1'],0.9936401987715706,0,0,1
313,Corticotropin-releasing hormone signaling pathway WP2355,0.9741925486416353,0.25609410430839,0.006695914901484741,['CRH'],0.9959102169234553,0,0,1
314,Hippo-Merlin Signaling Dysregulation WP4541,0.9741925486416353,0.25609410430839,0.006695914901484741,['HRAS'],0.9959102169234553,0,0,1
315,Insulin Signaling WP481,0.978832195048581,0.3227831076840312,0.006905962531704704,"['HRAS', 'PFKM']",0.9971354599906503,0,0,2
316,Calcium Regulation in the Cardiac Cell WP536,0.983383926367057,0.30647359454855194,0.005135170137268187,"['RGS16', 'ADRA1D']",0.9971354599906503,0,0,2
317,PI3K-Akt signaling pathway WP4172,0.984710096003228,0.4240391933028919,0.006533595851725335,"['RPS6', 'VEGFB', 'FGF1', 'HRAS', 'PCK2']",0.9971354599906503,0,0,5
318,TGF-beta Signaling Pathway WP366,0.9937146616273461,0.18027210884353742,0.0011366470627222746,['TGFBR2'],0.9984729908694522,0,0,1
319,Focal Adhesion WP306,0.9951627216922251,0.24449744463373083,0.001185571973428791,"['VEGFB', 'HRAS']",0.9984729908694522,0,0,2
320,Osteoblast differentiation WP4787,0.9964303546896417,0.1611170784103115,0.0005761597792908271,['FGF1'],0.9984729908694522,0,0,1
321,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9984729908694522,0.13891465677179962,0.00021228607192399658,['SST'],0.9984729908694522,0,0,1
